Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol

• Anna Figueiredo,

  Affiliations Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia , Department of Microbiology, Monash University, Clayton, Australia

  ⨯
• Katie L Moore,

  Affiliation Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia

  ⨯
• Johnson Mak,

  Affiliations HIV Assembly Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia , Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia

  ⨯
• Nicolas Sluis-Cremer,

  Affiliation Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Marie-Pierre de Bethune,

  Affiliation Tibotec Pharmaceuticals, Mechelen, Belgium

  ⨯
• Gilda Tachedjian

  *To whom correspondence should be addressed. E-mail: gildat@burnet.edu.au

  Affiliations Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia , Department of Microbiology, Monash University, Clayton, Australia , Department of Medicine, Monash University, Prahran, Australia

  ⨯